MC2078A1 - Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires - Google Patents
Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoiresInfo
- Publication number
- MC2078A1 MC2078A1 MC902086A MC2086A MC2078A1 MC 2078 A1 MC2078 A1 MC 2078A1 MC 902086 A MC902086 A MC 902086A MC 2086 A MC2086 A MC 2086A MC 2078 A1 MC2078 A1 MC 2078A1
- Authority
- MC
- Monaco
- Prior art keywords
- alezastine
- active ingredient
- inflammatory diseases
- ingredient against
- against psoriasis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/18—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels
- E02F3/20—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels
- E02F3/205—Dredgers; Soil-shifting machines mechanically-driven with digging wheels turning round an axis, e.g. bucket-type wheels with tools that only loosen the material, i.e. mill-type wheels with a pair of digging wheels, e.g. slotting machines
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
- E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
-
- E—FIXED CONSTRUCTIONS
- E02—HYDRAULIC ENGINEERING; FOUNDATIONS; SOIL SHIFTING
- E02F—DREDGING; SOIL-SHIFTING
- E02F3/00—Dredgers; Soil-shifting machines
- E02F3/04—Dredgers; Soil-shifting machines mechanically-driven
- E02F3/88—Dredgers; Soil-shifting machines mechanically-driven with arrangements acting by a sucking or forcing effect, e.g. suction dredgers
- E02F3/90—Component parts, e.g. arrangement or adaptation of pumps
- E02F3/92—Digging elements, e.g. suction heads
- E02F3/9212—Mechanical digging means, e.g. suction wheels, i.e. wheel with a suction inlet attached behind the wheel
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mechanical Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mining & Mineral Resources (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Structural Engineering (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Civil Engineering (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3900607 | 1989-01-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
MC2078A1 true MC2078A1 (fr) | 1991-01-07 |
Family
ID=6371863
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC902086A MC2078A1 (fr) | 1989-01-11 | 1990-01-04 | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires |
Country Status (15)
Country | Link |
---|---|
US (1) | US5110814A (pt) |
EP (2) | EP0378086B1 (pt) |
JP (1) | JP2991733B2 (pt) |
AT (2) | ATE113208T1 (pt) |
AU (1) | AU618443B2 (pt) |
CA (1) | CA2007480C (pt) |
DE (3) | DE59007288D1 (pt) |
DK (2) | DK0378086T3 (pt) |
EG (1) | EG19912A (pt) |
ES (2) | ES2061307T3 (pt) |
HK (2) | HK50595A (pt) |
IE (1) | IE65336B1 (pt) |
MC (1) | MC2078A1 (pt) |
PT (1) | PT92821B (pt) |
SG (2) | SG30593G (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3190441B2 (ja) * | 1992-07-20 | 2001-07-23 | エーザイ株式会社 | 塩酸アゼラスチンを含有する安定な製剤 |
NL9201438A (nl) * | 1992-08-11 | 1994-03-01 | Prospa Bv | Nieuwe farmaceutische samenstellingen die esters van omega-3 polyonverzadigde zuren omvatten en de toepassing ervan bij de plaatselijke behandeling van ziekelijke aandoeningen. |
CZ199593A3 (en) * | 1992-10-02 | 1994-04-13 | Asta Medica Ag | Phthalazinone derivatives exhibiting anti-arrhythmic and analgesic activity and eliminating resistance to a plurality of medicaments (mdr) |
US5569680A (en) * | 1995-02-13 | 1996-10-29 | Trustees Of The Univ. Of Penna | Method of treating inflammatory bowel disease with tributyrin |
JP4138910B2 (ja) * | 1997-07-02 | 2008-08-27 | 帝國製薬株式会社 | 経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤 |
US6984667B2 (en) * | 1998-04-08 | 2006-01-10 | Theta Biomedical Consulting And Development Co. | Synergistic proteoglycan compositions for inflammatory conditions |
DE19826517B4 (de) * | 1998-06-15 | 2006-03-23 | Baxter Healthcare S.A. | Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette |
DE10028638A1 (de) | 2000-06-09 | 2001-12-20 | Schuelke & Mayr Gmbh | Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern |
EP1677766B1 (de) * | 2003-10-31 | 2012-03-14 | Hexal AG | Pharmazeutische wirkstoffhaltige formulierung mit überzug |
WO2005077963A1 (fr) * | 2004-01-16 | 2005-08-25 | Institut Superieur Agricole De Beauvais | DErivEs de saccharides et d'itols possEdant un groupement O-alkyle ou un groupement O-alkyle et un groupement O-n-butanoyle. Applications comme mEdicaments dans les pathologies prolifEratives tumorales ou bEnignes. |
US20070020330A1 (en) * | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
US8758816B2 (en) * | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
MX2007006233A (es) | 2004-11-24 | 2007-11-23 | Medpointe Healthcare Inc | Composiciones que comprenden azelastina y metodos de uso de la misma. |
CA2906008C (en) | 2013-03-13 | 2019-07-09 | Flatley Discovery Lab, Llc | Pyridazinone compounds and methods for the treatment of cystic fibrosis |
US10835584B2 (en) * | 2016-06-17 | 2020-11-17 | Nuvothera, Inc. | Systems for treating dermal inflammatory conditions |
US11318144B2 (en) | 2019-04-12 | 2022-05-03 | LA PharmaTech Inc. | Compositions and methods for treating Alzheimer's disease and Parkinson's disease |
US10639314B1 (en) | 2019-04-30 | 2020-05-05 | LA PharmaTech Inc. | Method of treating Alzheimer's disease |
US11938139B2 (en) * | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
US10966989B2 (en) | 2019-04-12 | 2021-04-06 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders |
US11690849B2 (en) | 2019-04-12 | 2023-07-04 | LA PharmaTech Inc. | Method of treating dementia |
US11744833B2 (en) | 2019-04-12 | 2023-09-05 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of insomnia |
US11389458B2 (en) | 2019-04-12 | 2022-07-19 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treating parkinson's and huntington's disease |
US11351179B1 (en) | 2021-08-05 | 2022-06-07 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for treatment of psychiatric disorders |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3840606A (en) * | 1969-12-05 | 1974-10-08 | Oreal | Process of producing mono and polyhydroxyl ethers |
CH572914A5 (pt) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab | |
DE3343530A1 (de) * | 1983-12-01 | 1985-06-13 | Max Planck Gesellschaft | Arzneimittel mit verbesserter penetration der gewebsmembran |
US4871733A (en) * | 1984-04-09 | 1989-10-03 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
-
1989
- 1989-12-28 US US07/458,350 patent/US5110814A/en not_active Expired - Lifetime
-
1990
- 1990-01-03 SG SG1995905121A patent/SG30593G/en unknown
- 1990-01-03 EP EP90100071A patent/EP0378086B1/de not_active Expired - Lifetime
- 1990-01-03 AT AT90100071T patent/ATE113208T1/de not_active IP Right Cessation
- 1990-01-03 AT AT92119073T patent/ATE111735T1/de not_active IP Right Cessation
- 1990-01-03 ES ES92119073T patent/ES2061307T3/es not_active Expired - Lifetime
- 1990-01-03 DK DK90100071.1T patent/DK0378086T3/da active
- 1990-01-03 EP EP92119073A patent/EP0533213B1/de not_active Expired - Lifetime
- 1990-01-03 DE DE59007288T patent/DE59007288D1/de not_active Expired - Lifetime
- 1990-01-03 DE DE59007531T patent/DE59007531D1/de not_active Expired - Lifetime
- 1990-01-03 ES ES90100071T patent/ES2063841T3/es not_active Expired - Lifetime
- 1990-01-03 DE DE4000070A patent/DE4000070A1/de not_active Withdrawn
- 1990-01-03 SG SG1995905105A patent/SG30591G/en unknown
- 1990-01-03 DK DK92119073.2T patent/DK0533213T3/da active
- 1990-01-04 MC MC902086A patent/MC2078A1/xx unknown
- 1990-01-08 EG EG1090A patent/EG19912A/xx active
- 1990-01-10 AU AU47862/90A patent/AU618443B2/en not_active Expired
- 1990-01-10 CA CA002007480A patent/CA2007480C/en not_active Expired - Lifetime
- 1990-01-10 PT PT92821A patent/PT92821B/pt not_active IP Right Cessation
- 1990-01-10 IE IE9890A patent/IE65336B1/en not_active IP Right Cessation
- 1990-01-11 JP JP2002630A patent/JP2991733B2/ja not_active Expired - Lifetime
-
1995
- 1995-04-06 HK HK50595A patent/HK50595A/xx not_active IP Right Cessation
- 1995-04-06 HK HK50495A patent/HK50495A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5110814A (en) | 1992-05-05 |
AU4786290A (en) | 1990-07-19 |
EG19912A (en) | 1996-05-31 |
DK0533213T3 (da) | 1994-10-17 |
ES2061307T3 (es) | 1994-12-01 |
EP0533213A1 (de) | 1993-03-24 |
EP0378086B1 (de) | 1994-10-26 |
HK50595A (en) | 1995-04-13 |
EP0378086A3 (de) | 1991-02-06 |
DE59007531D1 (de) | 1994-12-01 |
DK0378086T3 (da) | 1994-12-12 |
IE900098L (en) | 1990-07-11 |
ES2063841T3 (es) | 1995-01-16 |
CA2007480A1 (en) | 1990-07-17 |
SG30593G (en) | 1995-09-18 |
JPH02288827A (ja) | 1990-11-28 |
CA2007480C (en) | 1995-08-15 |
DE59007288D1 (de) | 1994-10-27 |
ATE113208T1 (de) | 1994-11-15 |
AU618443B2 (en) | 1991-12-19 |
PT92821A (pt) | 1990-07-31 |
ATE111735T1 (de) | 1994-10-15 |
SG30591G (en) | 1995-09-18 |
JP2991733B2 (ja) | 1999-12-20 |
EP0533213B1 (de) | 1994-09-21 |
EP0378086A2 (de) | 1990-07-18 |
DE4000070A1 (de) | 1990-07-12 |
IE65336B1 (en) | 1995-10-18 |
HK50495A (en) | 1995-04-13 |
PT92821B (pt) | 1995-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MC2078A1 (fr) | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires | |
ZA919317B (en) | Novel hydroxamic acid and N-hydroxyurea derivatives and their use. | |
NO157020C (no) | Analogifremgangsmte ved fremstilling av terapeutisk aktive 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-aromatiske heterocykliske carboxylater. | |
SE7903186L (sv) | Cerebralverksamt medel | |
FI963424A (fi) | Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi | |
LU91125I2 (fr) | Ranélate den strontium et ses dérivés pharmaceutiquement acceptables (protelos). | |
PT716600E (pt) | Composicoes para administracao topica contendo derivados do acido 3-benzoilfenilacetico para o tratamento de doencas inflamatorias oftalmicas | |
NO146599C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt 6-klor-2-(1`-piperazinyl)-pyrazin og salter derav | |
NO162557C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive (pyrrol-1-yl)-fenyldihydropyridazinoner. | |
GR3006674T3 (pt) | ||
NO922136D0 (no) | Anvendelse av gibberelliner for behandling av prostatitisog psoriasis | |
NO810480L (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater | |
DE69103773D1 (de) | Derivate von hydroxaminsäure die lipoxygenase hemmen. | |
FI925518A (fi) | Menetelmä terapeuttisesti aktiivisten 1-piperidinyylialkanoyyliaryylisulfonamidijohdannaisten valmistamiseksi | |
SE8802323D0 (sv) | 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it | |
IT8448370A0 (it) | Citrato trisodico utilizzabile nella cura delle malattie artriticoreumatiche | |
IT7945204A0 (it) | Composizione farmaceutica per la terapia delle sterilita' maschile | |
IT8024347A0 (it) | L'applicazione di 4-arilchinazolin-2(1h)-oni per il trattamento delle malattie autoimmuni dei tessuti connettivi. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
YP | Annual fee paid |